Back to results
US 9,873,867 B2Granted
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
AssigneeBiomarin Pharmaceutical Inc.
InventorsErno Pungor, Charles Hague, Zhi Chen
Life of this patent
Estimating the term…
Abstract
This invention provides compositions of active highly phosphorylated lysosomal sulfatase enzymes, their pharmaceutical compositions, methods of producing and purifying such lysosomal sulfatase enzymes and compositions and their use in the diagnosis, prophylaxis, or treatment of diseases and conditions, including particularly lysosomal storage diseases that are caused by, or associated with, a deficiency in the lysosomal sulfatase enzyme.
Claims4
A method for producing an active highly phosphorylated recombinant human lysosomal sulfatase enzyme, comprising the steps of:
- (a) culturing a Chinese Hamster Ovary (CHO)-derived END3 complementation group cell defective in endosomal acidification;
- (b) preparing a first mammalian expression vector capable of expressing said active highly phosphorylated recombinant human lysosomal sulfatase enzyme in said END3 complementation group cell;
- (c) preparing a second mammalian expression vector capable of expressing recombinant human sulfatase modifying factor 1 (SUMF1) in said END3 complementation group cell;
- (d) transfecting said END3 complementation group cell with said first and second expression vectors;
- (e) selecting and cloning of a transfectant of said END3 complementation group cell that expresses said active highly phosphorylated recombinant human lysosomal sulfatase enzyme;
- and
- (f) optimizing a cell culture process method for manufacturing said highly phosphorylated recombinant human lysosomal sulfatase enzyme,
- wherein the recombinant human lysosomal sulfatase enzyme is selected from the group consisting of arylsulfatase A (ARSA), arylsulfatase B (ARSB), iduronate-2-sulfatase (IDS), sulfamidase/heparin-N-sulfatase (SGSH), N-acetylglucosamine-sulfatase (G6S) and N-acetylgalactosamine-6-sulfatase (GALNS).
5 more elements
Dependencies are inferred from the claim text.